CEACAM5 and breast carcinoma: A total of 73.7% (150/179) and 83.8% (132/179) of the hospitals failed to report any activity on CEA and CA 15–3 respectively, (CEA for colon cancer detection while CA 15–3 for monitoring prognosis of breast cancer therapy).